학술논문
Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN
Document Type
Article
Author
Source
In ESMO Open April 2022 7(2)
Subject
Language
ISSN
2059-7029